These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17020914)

  • 1. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus.
    Man JH; Li HY; Zhang PJ; Zhou T; He K; Pan X; Liang B; Li AL; Zhao J; Gong WL; Jin BF; Xia Q; Yu M; Shen BF; Zhang XM
    Nucleic Acids Res; 2006; 34(19):5552-66. PubMed ID: 17020914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
    Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
    J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.
    Zhang PJ; Zhao J; Li HY; Man JH; He K; Zhou T; Pan X; Li AL; Gong WL; Jin BF; Xia Q; Yu M; Shen BF; Zhang XM
    EMBO J; 2007 Apr; 26(7):1831-42. PubMed ID: 17347654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
    Li H; Fidler ML; Lim CS
    Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability.
    Nakagawa K; Kohara T; Uehata Y; Miyakawa Y; Sato-Ueshima M; Okubo N; Asaka M; Takeda H; Kobayashi M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):470-6. PubMed ID: 26697750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.
    Iwasaki K; Hailemariam K; Tsuji Y
    J Biol Chem; 2007 Aug; 282(31):22335-43. PubMed ID: 17565989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
    Ban R; Nishida T; Urano T
    Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential PIAS3 expression in human malignancy.
    Wang L; Banerjee S
    Oncol Rep; 2004 Jun; 11(6):1319-24. PubMed ID: 15138572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal activity-induced SUMOylation of Akt1 by PIAS3 is required for long-term potentiation of synaptic transmission.
    Meng L; Du CP; Lu CY; Zhang K; Li L; Yan JZ; Hou XY
    FASEB J; 2021 Aug; 35(8):e21769. PubMed ID: 34288124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide destabilizes Pias3 and regulates sumoylation.
    Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
    PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS3 may represent a potential biomarker for diagnosis and therapeutic of human colorectal cancer.
    Li H; Gao H; Bijukchhe SM; Wang Y; Li T
    Med Hypotheses; 2013 Dec; 81(6):1151-4. PubMed ID: 24120699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
    Dabir S; Kluge A; Dowlati A
    Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression.
    Deng J; Hua K; Caveney EJ; Takahashi N; Harp JB
    Biochem Biophys Res Commun; 2006 Jan; 339(3):923-31. PubMed ID: 16329991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
    Shao R; Egecioglu E; Weijdegård B; Ljungström K; Ling C; Fernandez-Rodriguez J; Billig H
    J Endocrinol; 2006 Sep; 190(3):857-70. PubMed ID: 17003286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on the effects of PIAS3 expression on the invasion of glioma TJ905 cells].
    Pan TH; Wang YY; Zhang SG; Zhang JX; Li R; Yan W; He AL; Wang ZM; Shi L
    Zhonghua Wai Ke Za Zhi; 2011 May; 49(5):440-4. PubMed ID: 21733403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth.
    Zhao Z; Wu L; Shi H; Wu C
    Mol Med Rep; 2014 May; 9(5):1903-8. PubMed ID: 24584189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.